Cilengitide Imaging Trial in Glioblastoma
Clinical trial NCT01558687 · TERMINATED
Trial details
- NCT number
- NCT01558687
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-02-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.